Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03608826 · ClinicalTrials.gov registry record · NA
Relationship Between LINQ™ Subcutaneous Impedance and Right-sided Hemodynamic Measurements
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03608826 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 12 participants.
The verdict
NCT03608826, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of the ReLINQuish study is to characterize the relationship between subcutaneous impedance and hemodynamic measurements in patients with heart failure. Additionally, the relationship between changes in subcutaneous impedance and other physiologic parameters during acute decompensated HF events will be characterized.
Interventions
- DEVICE Investigational LINQ™ HF RAMware
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-07-13 |
| Est. Completion | 2021-05-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03608826
The ClinicalTrials.gov registry entry for NCT03608826 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Investigational LINQ™ HF RAMware is the first listed.
NCT03608826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03608826 about?
NCT03608826 is a clinical study titled "Relationship Between LINQ™ Subcutaneous Impedance and Right-sided Hemodynamic Measurements". The purpose of the ReLINQuish study is to characterize the relationship between subcutaneous impedance and hemodynamic measurements in patients with heart failure. Additionally, the relationship between changes in subcutaneous impedance and other physiologic parameters during acute decompensated HF ...
What is the current status of trial NCT03608826?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-07-13. Estimated completion is 2021-05-07.
What interventions are being tested in trial NCT03608826?
The interventions under investigation include: Investigational LINQ™ HF RAMware (DEVICE).
Who is sponsoring clinical trial NCT03608826?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.